Page last updated: 2024-09-04

salvigenin and 5-hydroxy-3',4',6,7-tetramethoxyflavone

salvigenin has been researched along with 5-hydroxy-3',4',6,7-tetramethoxyflavone in 1 studies

Compound Research Comparison

Studies
(salvigenin)
Trials
(salvigenin)
Recent Studies (post-2010)
(salvigenin)
Studies
(5-hydroxy-3',4',6,7-tetramethoxyflavone)
Trials
(5-hydroxy-3',4',6,7-tetramethoxyflavone)
Recent Studies (post-2010) (5-hydroxy-3',4',6,7-tetramethoxyflavone)
270191507

Protein Interaction Comparison

ProteinTaxonomysalvigenin (IC50)5-hydroxy-3',4',6,7-tetramethoxyflavone (IC50)
Cytochrome P450 1A1Homo sapiens (human)1.38
Cytochrome P450 1A2Homo sapiens (human)0.9
Cytochrome P450 1B1Homo sapiens (human)2.5

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cutler, SJ; Elokely, KM; Klein, ML; Lambert, J; León, F; Mansoor, A; Pettaway, S; Tarawneh, A1

Other Studies

1 other study(ies) available for salvigenin and 5-hydroxy-3',4',6,7-tetramethoxyflavone

ArticleYear
Flavonoids from Perovskia atriplicifolia and Their in Vitro Displacement of the Respective Radioligands for Human Opioid and Cannabinoid Receptors.
    Journal of natural products, 2015, Jun-26, Volume: 78, Issue:6

    Topics: Flavones; Flavonoids; Humans; In Vitro Techniques; Lamiaceae; Ligands; Molecular Structure; Pakistan; Plant Leaves; Receptors, Cannabinoid; Receptors, Opioid, delta

2015